NCT00089609 2018-04-20
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
5 trialsNCT00362882 2017-12-05
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00459407 2014-10-08
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
National Cancer Institute (NCI)
Phase 1 Completed
NCT00689975 2013-08-26
Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00096590 2009-05-12
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
National Cancer Institute (NCI)
Completed